GLEN COVE HOSPITAL
1. Target Overview & Investment Thesis
GLEN COVE HOSPITAL is a 54-bed suburban community hospital in NASSAU, NY with $176.5M in net patient revenue and a -24.6% operating margin. The hospital serves a payer mix of 53.0% Medicare, 3.9% Medicaid, and 43.1% commercial.
Thesis: Turnaround. Our ML models identify $13.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -24.6% to -17.3% (+736bps).
| Net Revenue HCRIS | $176.5M |
| Current EBITDA COMPUTED | $-43.5M |
| Operating Margin COMPUTED | -24.6% |
| Occupancy HCRIS | 85.9% |
| Revenue / Bed COMPUTED | $3.3M |
| Net-to-Gross HCRIS | 23.1% |
| Distress Probability ML | 37.1% |
2. Market Context & Competitive Position
NY has 196 Medicare-certified hospitals with a median operating margin of -17.5%. The target's margin of -24.6% places it below the state median. Among 35 size-comparable peers (27-108 beds), the median margin is -13.1%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (27-108), prioritizing same-state peers. 35 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| GLEN COVE HOSPITAL (Target) | NY | 54 | $176.5M | -24.6% |
| CAYUGA MEDICAL CENTER AT ITHAC | NY | 107 | $302.3M | -13.1% |
| CANTON-POTSDAM HOSPITAL | NY | 94 | $231.6M | -5.7% |
| ST. JOSEPHS MEDICAL CENTER | NY | 106 | $212.9M | -24.1% |
| NORTHERN DUTCHESS HOSPITAL | NY | 79 | $176.1M | 4.9% |
| CORNING HOSPITAL | NY | 65 | $169.3M | 5.0% |
| ST. MARYS HEALTHCARE | NY | 100 | $151.8M | -21.9% |
| ONEIDA HEALTH | NY | 101 | $131.1M | -11.5% |
| AUBURN MEMORIAL HOSPITAL | NY | 85 | $129.6M | -8.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $13.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $3.7M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $3.5M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $3.5M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $2.1M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $113K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-43.5M |
| + RCM Uplift | +$13.0M |
| Pro Forma EBITDA | $-30.5M |
| Current Margin | -24.6% |
| Pro Forma Margin | -17.3% |
| WC Released (1x) | $6.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-66.9M | $-156.8M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-66.9M | $-194.2M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-60.2M | $-173.1M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-60.2M | $-206.6M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-73.6M | $-200.1M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-73.6M | $-244.0M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 35 hospitals with 27-108 beds
- Same-state prioritization (n=36)
- Comp margins: P25=-23.2% / P50=-13.1% / P75=-9.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.